Earnest Partners LLC Boosts Stake in Humana Inc. $HUM

Key Points

• Earnest Partners LLC increased its stake in Humana Inc. by 7.1%, now owning 35,880 shares valued at approximately $9.49 million.
• Multiple hedge funds, including Cary Street Partners and Whipplewood Advisors, significantly increased their holdings in Humana during the first quarter, reflecting growing institutional interest.
• Humana announced a $0.885 quarterly dividend to be paid on October 31st, with a current yield of 1.2% and an annual payout of $3.54 per share.

Earnest Partners LLC boosted its position in Humana Inc. (NYSE:HUM - Free Report) by 7.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 35,880 shares of the insurance provider's stock after purchasing an additional 2,378 shares during the period. Earnest Partners LLC's holdings in Humana were worth $9,494,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Transamerica Financial Advisors LLC boosted its position in Humana by 1,027.6% in the first quarter. Transamerica Financial Advisors LLC now owns 327 shares of the insurance provider's stock worth $87,000 after purchasing an additional 298 shares during the last quarter. Ieq Capital LLC boosted its position in Humana by 916.1% in the first quarter. Ieq Capital LLC now owns 56,188 shares of the insurance provider's stock worth $14,867,000 after purchasing an additional 50,658 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its position in Humana by 93.3% in the first quarter. Caisse DE Depot ET Placement DU Quebec now owns 94,990 shares of the insurance provider's stock worth $25,134,000 after purchasing an additional 45,839 shares during the last quarter. Islay Capital Management LLC purchased a new stake in Humana in the first quarter worth about $1,244,000. Finally, 53 House LLP purchased a new position in shares of Humana in the first quarter valued at about $9,769,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on HUM shares. Truist Financial decreased their target price on shares of Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a research report on Wednesday, July 16th. Barclays set a $275.00 price target on Humana and gave the company an "equal weight" rating in a research note on Thursday, July 31st. Wells Fargo & Company reduced their price objective on Humana from $348.00 to $344.00 and set an "overweight" rating for the company in a research note on Thursday, August 14th. Bank of America lowered their target price on shares of Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a research note on Tuesday, June 17th. Finally, Morgan Stanley decreased their price target on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a research note on Thursday, July 31st. Seven equities research analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $283.29.

Humana Stock Performance

Shares of NYSE:HUM traded up $6.01 during midday trading on Monday, hitting $303.90. The stock had a trading volume of 1,099,760 shares, compared to its average volume of 1,366,524. The stock has a 50 day moving average price of $254.43 and a two-hundred day moving average price of $254.59. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $36.55 billion, a PE ratio of 23.32, a P/E/G ratio of 1.79 and a beta of 0.44. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $382.72.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The company had revenue of $32.39 billion during the quarter, compared to analysts' expectations of $31.85 billion. During the same quarter in the prior year, the business earned $6.96 EPS. The business's revenue for the quarter was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, equities analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date is Friday, September 26th. Humana's dividend payout ratio (DPR) is currently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.